Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.08M Hold
2,994
0.38% 62
2026
Q1
$1.05M Hold
2,994
0.4% 56
2025
Q4
$980K Buy
2,994
+1
+0% +$317 0.37% 60
2025
Q3
$845K Buy
2,993
+2
+0.1% +$580 0.33% 62
2025
Q2
$835K Buy
2,991
+24
+0.8% +$6.8K 0.36% 62
2025
Q1
$924K Sell
2,967
-41
-1% -$12.1K 0.46% 49
2024
Q4
$784K Buy
3,008
+325
+12% +$96.4K 0.41% 50
2024
Q3
$865K Hold
2,683
0.46% 49
2024
Q2
$838K Sell
2,683
-19
-0.7% -$5.58K 0.52% 40
2024
Q1
$768K Sell
2,702
-99
-4% -$29K 0.48% 40
2023
Q4
$807K Buy
2,801
+1
+0% +$272 0.77% 34
2023
Q3
$753K Sell
2,800
-200
-7% -$49.9K 0.83% 31
2023
Q2
$675K Buy
3,000
+343
+13% +$79.6K 0.71% 33
2023
Q1
$702K Hold
2,657
0.76% 33
2022
Q4
$702K Buy
+2,657
New +$712K 0.76% 33

Other funds holding AMGN

Owen LaRue's AMGN Position: Q2 2026 in Review

Owen LaRue held its Amgen (AMGN) position steady in Q2 2026 at 2,994 shares worth $1.08M. The position accounts for 0.38% of the portfolio, ranked #62.

Owen LaRue first reported a position in AMGN in Q4 2022 and has held it in 15 quarters since. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Owen LaRue held 2,994 shares of Amgen worth $1.08M as of Q2 2026.
  • Owen LaRue left its Amgen share count unchanged in Q2 2026.
  • Amgen made up 0.38% of Owen LaRue's portfolio in Q2 2026, its #62 holding.
  • Owen LaRue first reported a position in Amgen in Q4 2022 and has held it in 15 quarters since.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Owen LaRue's 13F filing for Q2 2026, filed 22 Jul 2026.